UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Shopify
SHOP
|
+$873M |
| 2 |
Apple
AAPL
|
+$739M |
| 3 |
Accenture
ACN
|
+$450M |
| 4 |
iShares Russell Mid-Cap Value ETF
IWS
|
+$393M |
| 5 |
Salesforce
CRM
|
+$359M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.39B |
| 2 |
Infosys
INFY
|
+$641M |
| 3 |
Meta Platforms (Facebook)
META
|
+$621M |
| 4 |
JPMorgan Chase
JPM
|
+$483M |
| 5 |
Visa
V
|
+$477M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.05% |
| 2 | Healthcare | 12.84% |
| 3 | Consumer Discretionary | 11.61% |
| 4 | Financials | 11.34% |
| 5 | Communication Services | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Bank of Marin Bancorp
BMRC
$459M
| $324K | ﹤0.01% |
8,690
| – | – |
|
2577
Ecovyst
ECVT
$1.14B
| $323K | ﹤0.01% |
31,509
| – | – |
|
2578
McEwen Inc
MUX
$1.18B
| $322K | ﹤0.01% |
36,377
| – | – |
|
|
PAYA
2579
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
| $318K | ﹤0.01% |
50,211
+10,272
| +26% | +$83.4K |
|
2580
Brown-Forman Class A
BF.A
$13.3B
| $317K | ﹤0.01% |
4,672
| – | – |
|
|
CNR
2581
Core Natural Resources Inc
CNR
$4.45B
| $313K | ﹤0.01% |
+13,779
| New | +$357K |
|
|
AUD
2582
DELISTED
Audacy, Inc.
AUD
| $312K | ﹤0.01% |
121,519
| – | – |
|
2583
1st Source
SRCE
$2.12B
| $312K | ﹤0.01% |
6,289
| – | – |
|
|
LEV
2584
DELISTED
The Lion Electric Company
LEV
| $312K | ﹤0.01% |
+31,500
| New | +$355K |
|
|
SP
2585
DELISTED
SP Plus Corporation
SP
| $306K | ﹤0.01% |
10,857
| – | – |
|
2586
Talos Energy
TALO
$2.4B
| $301K | ﹤0.01% |
30,690
-1,188
| -4% | -$13.5K |
|
|
OGI
2587
Organigram Holdings
OGI
$139M
| $301K | ﹤0.01% |
+42,750
| New | +$363K |
|
|
VERV
2588
DELISTED
Verve Therapeutics
VERV
| $299K | ﹤0.01% |
+8,100
| New | +$340K |
|
|
ALX
2589
Alexander's
ALX
$1.41B
| $297K | ﹤0.01% |
1,140
| – | – |
|
|
RUBY
2590
DELISTED
Rubius Therapeutics, Inc
RUBY
| $296K | ﹤0.01% |
30,575
-1,723
| -5% | -$23.9K |
|
2591
Liquidity Services
LQDT
$1.32B
| $296K | ﹤0.01% |
+13,400
| New | +$298K |
|
2592
Ducommun
DCO
$2.98B
| $294K | ﹤0.01% |
6,293
| – | – |
|
2593
Rhythm Pharmaceuticals
RYTM
$7.96B
| $294K | ﹤0.01% |
29,431
+4,216
| +17% | +$47.4K |
|
2594
QCR Holdings
QCRH
$1.7B
| $290K | ﹤0.01% |
5,171
| – | – |
|
2595
4D Molecular Therapeutics
FDMT
$562M
| $289K | ﹤0.01% |
+13,182
| New | +$323K |
|
2596
Omeros
OMER
$959M
| $289K | ﹤0.01% |
44,932
+139
| +0.3% | +$1.01K |
|
2597
Koppers
KOP
$969M
| $286K | ﹤0.01% |
9,142
-593
| -6% | -$19.4K |
|
2598
Luxfer Holdings
LXFR
$458M
| $286K | ﹤0.01% |
14,800
| – | – |
|
2599
First Advantage
FA
$4.12B
| $286K | ﹤0.01% |
+15,000
| New | +$289K |
|
2600
Pulmonx
LUNG
$87.6M
| $285K | ﹤0.01% |
8,887
+2,241
| +34% | +$81.9K |
|
Similar funds
UBS AM's Q4 2021 Portfolio in Review
As of Q4 2021, UBS AM held 2,965 positions worth $261B, up 8.3% from $241B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM's Q4 2021 filing shows 219 new, 1,218 increased, 1,020 reduced and 126 closed positions. Its largest new stake was iShares Russell Mid-Cap Value ETF: 3,293,120 shares worth $403M. The largest sale was Microsoft, an estimated $1.39B.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- UBS AM's largest Q4 2021 buy was iShares Russell Mid-Cap Value ETF: 3,293,120 shares worth $403M.
- UBS AM added most to Shopify in Q4 2021, an estimated $873M increase.
- UBS AM's biggest Q4 2021 reduction was Microsoft, cutting an estimated $1.39B.
- UBS AM fully exited Baidu in Q4 2021, selling an estimated $360M.
- UBS AM's ten largest holdings make up 22% of its $261B portfolio in Q4 2021.
- UBS AM opened 219 new positions and closed 126 in Q4 2021.
- UBS AM's portfolio value rose 8.3% quarter-over-quarter to $261B.
Based on UBS AM's 13F filing for Q4 2021, filed 14 Feb 2022.